Identification of human S100A9 as a novel target for treatment of autoimmune disease via binding to quinoline-3-carboxamides (Q21145828)

From Wikidata

Jump to navigation Jump to search

scientific article

Identification of Human S100A9 as a Novel Target for Treatment of Autoimmune Disease via Binding to Quinoline-3-Carboxamides

Language	Label	Description	Also known as
English	Identification of human S100A9 as a novel target for treatment of autoimmune disease via binding to quinoline-3-carboxamides	scientific article	Identification of Human S100A9 as a Novel Target for Treatment of Autoimmune Disease via Binding to Quinoline-3-Carboxamides

Statements

scholarly article

0 references

Identification of human S100A9 as a novel target for treatment of autoimmune disease via binding to quinoline-3-carboxamides (English)

0 references

autoimmune disease

1 reference

based on heuristic

inferred from title

Thomas Joseph Vogl

3

object named as

Thomas Vogl

author given names

Thomas

author last names

Vogl

1 reference

16 August 2022

author name string

Per Björk

1

author given names

Per

author last names

Björk

1 reference

16 August 2022

Anders Björk

2

author given names

Anders

author last names

Björk

1 reference

16 August 2022

Martin Stenström

4

author given names

Martin

author last names

Stenström

1 reference

16 August 2022

David Liberg

5

author given names

David

author last names

Liberg

1 reference

16 August 2022

Anders Olsson

6

author given names

Anders

author last names

Olsson

1 reference

16 August 2022

Johannes Roth

7

author given names

Johannes

author last names

Roth

1 reference

16 August 2022

Fredrik Ivars

8

author given names

Fredrik

author last names

Ivars

1 reference

16 August 2022

Tomas Leanderson

9

author given names

Tomas

author last names

Leanderson

1 reference

16 August 2022

language of work or name

0 references

publication date

28 April 2009

0 references

0 references

7

0 references

e97

0 references

4

0 references

copyright license

Creative Commons Attribution 4.0 International

28 April 2009

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

Loss of S100A9 (MRP14) results in reduced interleukin-8-induced CD11b surface expression, a polarized microfilament system, and diminished responsiveness to chemoattractants in vitro

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671563

19 March 2017

RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671563

19 March 2017

Two calcium-binding proteins in infiltrate macrophages of rheumatoid arthritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671563

19 March 2017

Divalent Metal Ion Complexes of S100B in the Absence and Presence of Pentamidine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671563

19 March 2017

Mrp8 and Mrp14 are endogenous activators of Toll-like receptor 4, promoting lethal, endotoxin-induced shock

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671563

19 March 2017

S100 proteins in mouse and man: from evolution to function and pathology (including an update of the nomenclature)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671563

19 March 2017

Phagocyte-specific S100 proteins: a novel group of proinflammatory molecules

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671563

19 March 2017

The human S100 protein MRP-14 is a novel activator of the beta 2 integrin Mac-1 on neutrophils

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671563

19 March 2017

Ionomycin-regulated phosphorylation of the myeloid calcium-binding protein p14

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671563

19 March 2017

A method for the quantitative recovery of protein in dilute solution in the presence of detergents and lipids

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671563

7 April 2017

The biochemical basis of zinc physiology

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671563

7 April 2017

Effect of laquinimod on MRI-monitored disease activity in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671563

12 September 2017

MRP8/MRP14 impairs endothelial integrity and induces a caspase-dependent and -independent cell death program

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671563

12 September 2017

Biophysical characterization of S100A8 and S100A9 in the absence and presence of bivalent cations

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671563

12 September 2017

S100 proteins expressed in phagocytes: a novel group of damage-associated molecular pattern molecules

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671563

12 September 2017

Alarmins: chemotactic activators of immune responses

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671563

12 September 2017

Treatment with laquinimod reduces development of active MRI lesions in relapsing MS.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671563

12 September 2017

Proinflammatory S100 proteins in arthritis and autoimmune disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671563

12 September 2017

MRP8 and MRP14 control microtubule reorganization during transendothelial migration of phagocytes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671563

12 September 2017

S100 proteins: structure, functions and pathology

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671563

12 September 2017

Low dose linomide in Type I juvenile diabetes of recent onset: a randomised placebo-controlled double blind trial.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671563

12 September 2017

Treatment of chronic-relapsing experimental autoimmune encephalomyelitis with the synthetic immunomodulator linomide (quinoline-3-carboxamide).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671563

12 September 2017

A designed TLR4/MD-2 complex to capture LPS.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671563

27 September 2017

Suppression of experimental autoimmune encephalomyelitis by selective blockade of encephalitogenic T-cell infiltration of the central nervous system

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671563

27 September 2017

The S100 family heterodimer, MRP-8/14, binds with high affinity to heparin and heparan sulfate glycosaminoglycans on endothelial cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671563

27 September 2017

High level expression and dimer characterization of the S100 EF-hand proteins, migration inhibitory factor-related proteins 8 and 14.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671563

27 September 2017

The expanding role of quantitative structure-activity relationships (QSAR) in toxicology

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671563

27 September 2017

S100A8 and S100A9 in human arterial wall. Implications for atherogenesis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671563

29 November 2018

Synthesis and biological evaluation of new 1,2-dihydro-4-hydroxy-2-oxo-3-quinolinecarboxamides for treatment of autoimmune disorders: structure-activity relationship

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671563

29 November 2018

The new orally active immunoregulator laquinimod (ABR-215062) effectively inhibits development and relapses of experimental autoimmune encephalomyelitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671563

29 November 2018

A null mutation in the inflammation-associated S100 protein S100A8 causes early resorption of the mouse embryo.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671563

29 November 2018

Treatment of secondary progressive multiple sclerosis with the immunomodulator linomide: a double-blind, placebo-controlled pilot study with monthly magnetic resonance imaging evaluation

1 reference

https://pubmed.ncbi.nlm.nih.gov/19402754

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Linomide reduces the rate of active lesions in relapsing-remitting multiple sclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/19402754

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Absence of S100A12 in mouse: implications for RAGE-S100A12 interaction

1 reference

https://pubmed.ncbi.nlm.nih.gov/19402754

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of LS-2616 administration upon the autoimmune disease of (NZB x NZW) F1 hybrid mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/19402754

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Paradoxical effects of LS-2616 (Linomide) treatment in the type II collagen arthritis model in mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/19402754

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Linomide, a novel immunomodulator that prevents death in four models of septic shock

1 reference

https://pubmed.ncbi.nlm.nih.gov/19402754

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Myeloid-related proteins 8 and 14 induce a specific inflammatory response in human microvascular endothelial cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/19402754

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hexameric calgranulin C (S100A12) binds to the receptor for advanced glycated end products (RAGE) using symmetric hydrophobic target-binding patches

1 reference

https://pubmed.ncbi.nlm.nih.gov/19402754

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Linomide in relapsing and secondary progressive MS: part I: trial design and clinical results. North American Linomide Investigators

1 reference

https://pubmed.ncbi.nlm.nih.gov/19402754

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phosphorylation of MRP14, an S100 protein expressed during monocytic differentiation, modulates Ca(2+)-dependent translocation from cytoplasm to membranes and cytoskeleton

1 reference

https://pubmed.ncbi.nlm.nih.gov/19402754

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1371/JOURNAL.PBIO.1000097

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

release_qkujopvzjrgczh6t4h72tjezce

0 references

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q21145828&oldid=1871152021"